SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is trending downward following a significant post-earnings sell-off driven by weak future sales guidance and concerns over the company's turnaround progress in key international markets. The investor community remains sharply divided, with some actively buying the dip as a long-term value play, while others criticize the brand's loss of cultural relevance and competitive positioning against emerging sportswear rivals.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors react to the company's fiscal Q3 earnings report, which highlighted record revenue and international growth, though community sentiment remains polarized over management and the stock's long-term performance. While some participants are betting on an upside reversal tied to broader cannabis sector catalysts and rescheduling prospects, others remain skeptical, citing concerns over dilution and historical share price declines.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors weigh recent capital allocation moves, including a multi-billion dollar stake repurchase in its Irish manufacturing site, against broader market volatility and geopolitical concerns affecting the semiconductor sector. While the community remains divided between long-term bulls highlighting foundry expansion and AI growth and short-term bears skeptical of manufacturing headwinds, active discussion is dominated by the stock's pronounced intraday volatility and its sensitivity to macroeconomic headlines.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating significant buzz as investors track positive Phase 3 clinical data for its lead skin disease treatment, sonelokimab, while speculating on the potential for a high-premium buyout. The community remains deeply divided, with some retail investors holding for generational wealth based on clinical performance while others warn of price manipulation, short-selling pressure, and the impact of institutional divestments.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors focus on the commercial launch of YARTEMLEA, with the community closely tracking initial patient uptake, formulary approvals at major transplant centers, and the company's timeline for reaching positive cash flow. While the stock has faced downward pressure due to technical factors and broader market volatility, discussions are heavily centered on upcoming Q1 sales updates, the potential for milestone payments from the Novo Nordisk partnership, and imminent EU regulatory milestones.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

Restoration Hardware is currently experiencing intense volatility following a significant earnings miss and lowered guidance, with the stock drawing heavy attention due to its massive short interest and the ongoing debate over whether it is a value play or a potential bankruptcy candidate. The community is sharply divided, with bulls betting on a short squeeze and long-term luxury market recovery, while bears point to persistent housing market headwinds, tariff-related margin compression, and expensive international expansion as signs of long-term deterioration.

SharonAI Holdings, Inc. engages in providing high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure technologies. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is experiencing heightened investor interest following the announcement of a massive multi-year AI cloud infrastructure agreement, which has sparked intense debate over the stock's potential for a significant short squeeze. Community members are actively discussing the company's low float and the strategic impact of this contract, leading to speculation about aggressive price moves while some remain cautious of potential spoofing and market volatility.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor ongoing project developments, including the upcoming pilot plant operations and the status of the Definitive Feasibility Study. Market participants are actively debating the stock's valuation relative to its rare earth assets while navigating volatility driven by broader sector trends and geopolitical developments.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors gear up for the upcoming 10-K filing and earnings report, with community members closely tracking the company's aggressive debt reduction efforts and the performance of key holdings like Applied Digital and BW. Bullish participants are actively discussing a potential valuation re-rating and the possibility of a short squeeze, while keeping a watchful eye on management's next steps to address previous legal overhangs and restore institutional confidence.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing significant speculative activity as traders draw comparisons to its past parabolic runs, fueled by a combination of tight float, high short interest, and persistent community speculation regarding a potential meme-style short squeeze. While bulls are actively targeting rapid gains and waiting for volume-driven breakouts, a vocal segment of the community remains skeptical, frequently highlighting the company's lack of revenue and warning others about the risks of being left as exit liquidity in a pump-and-dump setup.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

"Matter of pride": Solar Group Chairman Satyanarayan Nuwal on receiving Padma Shri

Nagpur (Maharashtra) [India], January 26 (ANI): Satyanarayan Nuwal, the founder and chairman of Solar Industries India Limited, has been conferred with Padma Shri for his contribution to Trade and Industry. His company manufactures defence products, including the 'Nagastra,' India's first indigenous loitering munition, used in Operation Sindoor. The company also produces Pinaka rockets, Rudrastra drones,

Shares of Solar Industries slipped over 3% on Thursday after the company reported an explosion at its crystallization building in Nagpur, Maharashtra.According to a press release dated September 4, Solar Industries said that the explosion happened just after midnight during the crystallization process of an energetic material.Despite safety systems being activated immediately, the shock impact of the explosion led to the loss of one life and injuries to eight others in nearby areas.The company has informed concerned departments and statutory authorities, and a thorough investigation is underway to determine the causes. The financial impact of the incident is confined to the affected building, the company said.At the time of writing, <a href="https://stocktwits.com/symbol/SOLARINDS.NSE">Solar Industries’ shares</a> were down 2%.Year-to-date, the stock has seen strong buying interest, gaining over 43%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 A worker installs solar panels containing photovoltaic cells at the new Solarpark Eggersdorf solar park on September 4, 2012 near Muencheberg, Germany. 

Solar Industries’ Stock Slips Following A Blast At Its Nagpur Facility

The company reported that an explosion took place during the crystallization process of an energetic material

Equity

Shares of Solar Industries slipped 8% this week even as the stock was upgraded to largecap by the Association of Mutual Funds in India (AMFI) in its latest classification.&nbsp;The company’s transformation into a defense-first company has impressed analysts, however they are concerned about its valuations, given Solar Industries has rallied nearly 60% so far this year.&nbsp;According to SEBI-registered investment advisor&nbsp;<a href="https://stocktwits.com/TrueNorth_Capital">TrueNorth Capital</a>, defence was once a small part of Solar’s operations but has rapidly grown—rising 160% in FY25 and doubling its share of revenue from 9% to 18%.&nbsp;<stembedurl>https://stocktwits.com/TrueNorth_Capital/message/620435609</stembedurl>The company now expects defence sales to reach ₹3,000 crore in FY26, or about one-third of total revenue, amid heightened military demand and fast-tracked orders following tensions on India’s western borders.Strong Defense Pipeline<a href="https://stocktwits.com/symbol/SOLARINDS.NSE">Solar Industries</a> recently secured a ₹6,000 crore contract for the Pinaka rocket system and is investing heavily in R&amp;D in collaboration with DRDO.&nbsp;After deploying its Nagastra-1 drone in Operation Sindoor, it’s now progressing with Nagastra-2 and -3, while its Bhargavastra micro-missile system has cleared key trials.To support its pipeline, Solar plans ₹2,500 crore in FY26 capex.&nbsp;International revenue now contributes 38% of sales, with facilities in Thailand and Indonesia and more on the way in Saudi Arabia and Kazakhstan.&nbsp;Solar wrapped up FY25 with a total order book of ₹17,000 crore, including ₹8,500 crore worth of defence contracts lined up over the next few years.Solar reported ₹7,500 crore in revenue for FY25 and is aiming to grow that by 33% in FY26.&nbsp;Looking ahead, the company is eyeing ₹20,000 crore in annual revenue over the next 4–5 years, with ₹8,000 crore expected from its rapidly expanding defence business.However, the advisor flagged risks such as soft coal and mining demand, overexposure to countries like Turkey (10% of revenue), and customer concentration.&nbsp;The stock trades at nearly 100x FY26 earnings, making it sensitive to any execution missteps, according to them.On Stocktwits, retail sentiment was ‘bearish’ amid ‘normal’ message volume.The stock has risen 57.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Solar’s Defense Play Is Paying Off But Valuations Raise Concerns, Says SEBI RA 

The analyst highlighted Solar Industries’ growing international footprint and strong FY26 guidance, but cautioned that risks like customer concentration and geopolitical exposure could weigh on execution.

Indian billionaires buck market trends, post strong gains in first half of 2025

Satyanarayan Nuwal of Solar Industries India tops Bloomberg Billionaire Index

Four stocks show strong breakout potential, with clear technical momentum and buying opportunities across key sectors, according to SEBI-registered analyst Sameer Pande.<stembedurl>https://stocktwits.com/sameerpande/message/615327037</stembedurl><ul><li><a href="https://stocktwits.com/symbol/SOLARINDS.NSE">Solar Industries India shares</a> remain close to&nbsp;their 52-week monthly high due to intense buying pressure and positive momentum, Pande said.&nbsp;He identified key support levels at ₹12,500–12,300 and ₹11,300–11,000,&nbsp;serving as demand zones where buyers are likely to enter the market.&nbsp;Based on ongoing stock momentum, the analyst projects a target price range of ₹15,000–16,000. He recommends a stop-loss order at ₹10,500 to control potential losses from declining prices.</li><li>According to Pande,&nbsp;<a href="https://stocktwits.com/symbol/GABRIEL.NSE">Gabriel India shares</a> exhibit strength across monthly, weekly, and daily charts, consistently making new highs.He advises initiating positions within the ₹660–630 range, which he considers an optimal entry point supported by technical demand.&nbsp;The expected upside targets lie between ₹740 and ₹790, while a stop-loss at ₹600 is suggested to limit potential losses in case of a reversal.</li><li><a href="https://stocktwits.com/symbol/DRREDDY.NSE">Shares of Dr. Reddy’s Laboratories</a>&nbsp;show positive momentum, with notable reversal signals on the monthly timeframe. This indicates potential trend continuation, Pande said.He highlights the stock’s capacity to rally toward ₹1,400–1,560 levels, recommending a stop-loss at ₹1,180 on a closing basis.</li><li><a href="https://stocktwits.com/symbol/BEL.NSE">Shares of Bharat Electronics</a>, a PSU known for defense electronics and expansion into sectors like smart cities and energy storage,&nbsp;are seeing breakout trends on daily and weekly charts, according to Pande.He encourages buying the stock at current levels, with an upside target range of ₹430–475 and a stop-loss at ₹350 on&nbsp;a closing basis.</li></ul>So far in 2025, Solar Industries has risen 43.2%, Gabriel is up 32.7%, Dr. Reddy’s has declined 10.7%, and Bharat Electronics has increased 28.2%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Which Breakout Stocks Should Investors Watch Now? SEBI RA Sameer Pande Highlights 4 Picks

The analyst identified key support, target, and stop-loss levels for four stocks with strong breakout potential and clear technical momentum.

Indian defense stocks rise by $5 billion amid tensions with Pakistan Bloomberg

According to the news agency, the market value of India's 10 leading arms manufacturers, including Hindustan Aeronautics and Solar Industries India, has increased by more than 5%

Solar Industries India Ltd. engages in the designing, manufacturing, supply and export of industrial explosives, initiating systems and space sector. Its products include: Initiating Systems, Packaged Explosives, Bulk Explosives, High Energy Materials, Composite Propellants, Complete integration of Rockets, Ammunitions, Drones and Unmanned Aerial Vehicle's (UAV), Pyros and Ignitors, and Propellants for Space Applications. The company was founded by Satyanarayan Nandlal Nuwal on February 24, 1995 and is headquartered in Nagpur, India.

Current Price	12,849.00
Prev Close	12,033.00
Open	12,420.00
Dividend Yield	0.09%
50-Day Moving Average	13,442.80
Beta	-0.05
Avg. Volume	247,781.42
PE Ratio	79.81

52-Week High	17,820.00
52-Week Low	9,888.40
Market Capitalization	1.09T
EPS (Annual)	133.65
Price to Book	22.65
Revenue Per Employee	10.54M

SOLARINDS.NSE
Solar Industries India Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SOLARINDS.NSE News

SOLARINDS.NSESolar Industries India Ltd